KARUNA THERAPEUTICS INC's ticker is KRTX and the CUSIP is 48576A100. A total of 257 filers reported holding KARUNA THERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is 1.01 and the average weighting 0.6%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $4,329,211 | -31.0% | 25,603 | -11.6% | 0.01% | -22.2% |
Q2 2023 | $6,278,458 | +36.3% | 28,953 | +14.2% | 0.02% | +28.6% |
Q1 2023 | $4,605,301 | -12.7% | 25,354 | -5.5% | 0.01% | -17.6% |
Q4 2022 | $5,273,078 | -14.0% | 26,835 | -1.6% | 0.02% | -10.5% |
Q3 2022 | $6,135,000 | +112.3% | 27,276 | +19.4% | 0.02% | +137.5% |
Q2 2022 | $2,890,000 | -20.6% | 22,847 | -20.4% | 0.01% | 0.0% |
Q1 2022 | $3,639,000 | -3.2% | 28,700 | 0.0% | 0.01% | +14.3% |
Q4 2021 | $3,760,000 | +7.1% | 28,700 | 0.0% | 0.01% | 0.0% |
Q3 2021 | $3,511,000 | +7.3% | 28,700 | 0.0% | 0.01% | 0.0% |
Q2 2021 | $3,272,000 | +27.8% | 28,700 | +34.7% | 0.01% | +40.0% |
Q1 2021 | $2,561,000 | +0.4% | 21,300 | -15.1% | 0.01% | -16.7% |
Q4 2020 | $2,550,000 | +12.9% | 25,100 | -14.0% | 0.01% | 0.0% |
Q3 2020 | $2,258,000 | +17.1% | 29,200 | +68.8% | 0.01% | +20.0% |
Q2 2020 | $1,928,000 | +64.2% | 17,300 | +6.1% | 0.01% | +25.0% |
Q1 2020 | $1,174,000 | +125.8% | 16,300 | +136.2% | 0.00% | +300.0% |
Q4 2019 | $520,000 | – | 6,900 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Pivotal bioVenture Partners Investment Advisor LLC | 908,708 | $109,254,000 | 35.05% |
Sofinnova Investments, Inc. | 1,952,441 | $234,742,000 | 14.11% |
Logos Global Management LP | 200,000 | $24,046,000 | 2.35% |
First Light Asset Management, LLC | 258,500 | $31,079,000 | 2.06% |
Eventide Asset Management | 971,077 | $116,753,000 | 1.73% |
DAFNA Capital Management LLC | 48,000 | $5,771,000 | 1.37% |
CATALYST PRIVATE WEALTH, LLC | 13,006 | $1,564,000 | 1.10% |
Rock Springs Capital Management LP | 368,764 | $44,336,000 | 0.97% |
Pinz Capital Management, LP | 28,805 | $3,463,000 | 0.92% |
MILLER VALUE PARTNERS, LLC | 291,239 | $35,016,000 | 0.91% |